References
- Shore SE, Roberts LE, Langguth B. Maladaptive plasticity in tinnitus–triggers, mechanisms and treatment. Nat Rev Neurol. 2016;12(3):150–160.
- Hoffman HJ, Reed GW. Epidemiology of tinnitus. In: Snow JB, editor. Tinnitus: theory and management. London: BC Decker; 2004. p. 16–41.
- Gallus S, Lugo A, Garavello W, et al. Prevalence and determinants of tinnitus in the italian adult population. Neuroepidemiology. 2015;45(1):12–19.
- Davis A, Refaie AE. Epidemiology of tinnitus. In: Tyler RS, editor. Handbook of tinnitus. San Diego: Singular thompson Learning; 2000. p. 1–24.
- Cima RFF, Vlaeyen JWS, Maes IHL, et al. Tinnitus interferes with daily life activities: A psychometric examination of the tinnitus disability index. Ear Hear. 2011;32(5):623–633.
- Langguth B. A review of tinnitus symptoms beyond ‘ringing in the ears’: A call to action. Curr Med Res Opin. 2011;27(8):1635–1643.
- Friberg E, Jansson C, Mittendorfer-Rutz E, et al. Sickness absence due to otoaudiological diagnoses and risk of disability pension: A nationwide swedish prospective cohort study. PLoS One. 2012;7(1):e29966.
- Maes IH, Cima RF, Vlaeyen JW, et al. Tinnitus: A cost study. Ear Hear. 2013;34(4):508–514.
- Martinez C, Wallenhorst C, McFerran D, et al. Incidence rates of clinically significant tinnitus: 10-year trend from a cohort study in england. Ear Hear. 2015;36(3):e69–75.
- Stockdale D, McFerran D, Brazier P, et al. An economic evaluation of the healthcare cost of tinnitus management in the uk. BMC Health Serv Res. 2017;17(1):577.
- Nondahl DM, Cruickshanks KJ, Wiley TL, et al. The ten-year incidence of tinnitus among older adults. Int J Audiol. 2010;49(8):580–585.
- Cederroth CR, Canlon B, Langguth B. Hearing loss and tinnitus–are funders and industry listening?. Nat Biotechnol. 2013;31(11):972–974.
- Langguth B, Elgoyhen AB. Current pharmacological treatments for tinnitus. Expert Opin Pharmacother. 2012;13(17):2495–2509.
- Vio MM, Holme RH. Hearing loss and tinnitus: 250 million people and a us$10 billion potential market. Drug Discov Today. 2005;10(19):1263–1265.
- Wilson BS, Tucci DL, Merson MH, et al. Global hearing health care: new findings and perspectives. Lancet. 2017;390(10111):2503–2515.
- Lancet T. Hearing loss: time for sound action. Lancet. 2017;390(10111):2414.
- Hoare DJ, Edmondson-Jones M, Sereda M, et al. Amplification with hearing aids for patients with tinnitus and co-existing hearing loss. Cochrane Database Syst Rev. 2014;1:CD010151.
- Hobson J, Chisholm E, El Refaie A. Sound therapy (masking) in the management of tinnitus in adults. Cochrane Database Syst Rev. 2012;11:CD006371.
- Baldo P, Doree C, Molin P, et al. Antidepressants for patients with tinnitus. Cochrane Database Syst Rev. 2012;9:CD003853.
- Hilton MP, Zimmermann EF, Hunt WT. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev. 2013;3:CD003852.
- Hoekstra CE, Rynja SP, van Zanten GA, et al. Anticonvulsants for tinnitus. Cochrane Database Syst Rev. 2011;7:CD007960.
- Bennett MH, Kertesz T, Perleth M, et al. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev. 2012;10:CD004739.
- Park J, White AR, Ernst E. Efficacy of acupuncture as a treatment for tinnitus: A systematic review. Arch Otolaryngol Head Neck Surg. 2000;126(4):489–492.
- Meng Z, Liu S, Zheng Y, et al. Repetitive transcranial magnetic stimulation for tinnitus. Cochrane Database Syst Rev. 2011;10:CD007946.
- Hesser H, Weise C, Westin VZ, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive-behavioral therapy for tinnitus distress. Clin Psychol Rev. 2011;31(4):545–553.
- El-Shunnar SK, Hoare DJ, Smith S, et al. Primary care for tinnitus: practice and opinion among gps in england. J Eval Clin Pract. 2011;17(4):684–692.
- Cima RF, Maes IH, Joore MA, et al. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: A randomised controlled trial. Lancet. 2012;379(9830):1951–1959.
- Langguth B. Tinnitus: the end of therapeutic nihilism. Lancet. 2012;379(9830):1926–1928.
- Kreuzer PM, Vielsmeier V, Langguth B. Chronic tinnitus: an interdisciplinary challenge. Dtsch Arztebl Int. 2013;110(16):278–284.
- Langguth B, Elgoyhen AB, Cederroth CR. Therapeutic approaches to the treatment of tinnitus. Annu Rev Pharmacol Toxicol. 2018.
- Turner J, Larsen D, Hughes L, et al. Time course of tinnitus development following noise exposure in mice. J Neurosci Res. 2012;90(7):1480–1488.
- Turner JG. Behavioral measures of tinnitus in laboratory animals. Prog Brain Res. 2007;166:147–156.
- Landgrebe M, Azevedo A, Baguley D, et al. et al: methodological aspects of clinical trials in tinnitus: A proposal for an international standard. J Psychosom Res. 2012;73(2):112–121.
- Langguth B, Goodey R, Azevedo A, et al. Consensus for tinnitus patient assessment and treatment outcome measurement: tinnitus research initiative meeting, regensburg, july 2006. Prog Brain Res. 2007;166:525–536.
- Londero A, Hall DA. Call for an evidence-based consensus on outcome reporting in tinnitus intervention studies. Front Med (Lausanne). 2017;4:42.
- Brozoski TJ, Bauer CA. Animal models of tinnitus. Hear Res. 2016;338:88–97.
- von der Behrens W. Animal models of subjective tinnitus. Neural Plast. 2014;2014:741452.
- Eggermont JJ. Can animal models contribute to understanding tinnitus heterogeneity in humans?. Front Aging Neurosci. 2016;8:265.
- Elgoyhen AB, Langguth B, De Ridder D, et al. Tinnitus: perspectives from human neuroimaging. Nat Rev Neurosci. 2015;16(10):632–642.
- Landgrebe M, Zeman F, Koller M, et al. The tinnitus research initiative (tri) database: A new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcome. BMC Med Inform Decis Mak. 2010;10:42.
- Schlee W, Pryss RC, Probst T, et al. Measuring the moment-to-moment variability of tinnitus: the trackyourtinnitus smart phone app. Front Aging Neurosci. 2016;8:294.
- De Ridder D, Elgoyhen AB, Romo R, et al. Phantom percepts: tinnitus and pain as persisting aversive memory networks. Proc Natl Acad Sci U S A. 2011;108(20):8075–8080.
- De Ridder D, Vanneste S, Freeman W. The bayesian brain: phantom percepts resolve sensory uncertainty. Neurosci Biobehav Rev. 2014;44C:4–15.
- Schaette R. Tinnitus in men, mice (as well as other rodents), and machines. Hear Res. 2013;311:63–71.
- Ruttiger L, Singer W, Panford-Walsh R, et al. The reduced cochlear output and the failure to adapt the central auditory response causes tinnitus in noise exposed rats. PLoS One. 2013;8(3):e57247.
- Eggermont JJ, Roberts LE. The neuroscience of tinnitus: understanding abnormal and normal auditory perception. Front Syst Neurosci. 2012;6:53.
- De Ridder D, Vanneste S, Weisz N, et al. An integrative model of auditory phantom perception: tinnitus as a unified percept of interacting separable subnetworks. Neurosci Biobehav Rev. 2014;44C:16–32.
- Hebert S, Canlon B, Hasson D. Emotional exhaustion as a predictor of tinnitus. Psychother Psychosom. 2012;81(5):324–326.
- Rauschecker JP, Leaver AM, Muhlau M. Tuning out the noise: limbic-auditory interactions in tinnitus. Neuron. 2010;66(6):819–826.
- Chen YC, Li X, Liu L, et al. Tinnitus and hyperacusis involve hyperactivity and enhanced connectivity in auditory-limbic-arousal-cerebellar network. Elife. 2015;4:e06576.
- Sedley W, Gander PE, Kumar S, et al. Intracranial mapping of a cortical tinnitus system using residual inhibition. Curr Biol. 2015;25(9):1208–1214.
- Guitton MJ, Caston J, Ruel J, et al. Salicylate induces tinnitus through activation of cochlear nmda receptors. J Neurosci. 2003;23(9):3944–3952.
- Ruel J, Chabbert C, Nouvian R, et al. Salicylate enables cochlear arachidonic-acid-sensitive nmda receptor responses. J Neurosci. 2008;28(29):7313–7323.
- Eybalin M. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol Rev. 1993;73(2):309–373.
- Guitton MJ, Dudai Y. Blockade of cochlear nmda receptors prevents long-term tinnitus during a brief consolidation window after acoustic trauma. Neural Plast. 2007;2007:80904.
- d’Aldin CG, Ruel J, Assie R, et al. Implication of nmda type glutamate receptors in neural regeneration and neoformation of synapses after excitotoxic injury in the guinea pig cochlea. Int J Dev Neurosci. 1997;15(4–5):619–629.
- Puel JL, Pujol R, Tribillac F, et al. Excitatory amino acid antagonists protect cochlear auditory neurons from excitotoxicity. J Comp Neurol. 1994;341(2):241–256.
- Duan M, Agerman K, Ernfors P, et al. Complementary roles of neurotrophin 3 and a n-methyl-d-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicity. Proc Natl Acad Sci U S A. 2000;97(13):7597–7602.
- Lobarinas E, Yang G, Sun W, et al. Salicylate- and quinine-induced tinnitus and effects of memantine. Acta Otolaryngol Suppl. 2006;126:13–19.
- Zheng Y, McNamara E, Stiles L, et al. Evidence that memantine reduces chronic tinnitus caused by acoustic trauma in rats. Front Neurol. 2012;3:127.
- Ralli M, Troiani D, Podda MV, et al. The effect of the nmda channel blocker memantine on salicylate-induced tinnitus in rats. Acta Otorhinolaryngol Ital. 2014;34(3):198–204.
- Criddle MW, Godfrey DA, Kaltenbach JA. Attenuation of noise-induced hyperactivity in the dorsal cochlear nucleus by pre-treatment with mk-801. Brain Res. 2018;1682:71–77.
- Wenzel GI, Warnecke A, Stover T, et al. Effects of extracochlear gacyclidine perfusion on tinnitus in humans: A case series. Eur Arch Otorhinolaryngol. 2010;267(5):691–699.
- van de Heyning P, Muehlmeier G, Cox T, et al. Efficacy and safety of am-101 in the treatment of acute inner ear tinnitus–a double-blind, randomized, placebo-controlled phase ii study. Otol Neurotol. 2014;35(4):589–597.
- Bing D, Lee SC, Campanelli D, et al. Cochlear nmda receptors as a therapeutic target of noise-induced tinnitus. Cell Physiol Biochem. 2015;35(5):1905–1923.
- Singer W, Zuccotti A, Jaumann M, et al. Noise-induced inner hair cell ribbon loss disturbs central arc mobilization: A novel molecular paradigm for understanding tinnitus. Mol Neurobiol. 2013;47(1):261–279.
- Am-101 in the treatment of acute tinnitus 2. 2018. https://clinicaltrials.gov/ct2/show/NCT01803646?term=AM-101&rank=4
- Am-101 in the treatment of acute tinnitus 3. 2018. https://clinicaltrials.gov/ct2/show/NCT02040194?term=AM-101&rank=3
- Faught E. Bgg492 (selurampanel), an ampa/kainate receptor antagonist drug for epilepsy. Expert Opin Investig Drugs. 2014;23(1):107–113.
- Lee AC, Godfrey DA. Cochlear damage affects neurotransmitter chemistry in the central auditory system. Front Neurol. 2014;5:227.
- Muly SM, Gross JS, Potashner SJ. Noise trauma alters d-[3h]aspartate release and ampa binding in chinchilla cochlear nucleus. J Neurosci Res. 2004;75(4):585–596.
- https://www.novctrd.com/CtrdWeb/displaypdf.nov?trialresultid=12123
- Chambers AR, Pilati N, Balaram P, et al. Pharmacological modulation of kv3.1 mitigates auditory midbrain temporal processing deficits following auditory nerve damage. Sci Rep. 2017;7(1):17496.
- Glait L, Fan W, Stillitano G, et al. Effects of aut00063, a kv3.1 channel modulator, on noise-induced hyperactivity in the dorsal cochlear nucleus. Hear Res. 2018;361:36–44.
- 2016. https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002179-27/results
- Sanchez VA, Hall DA, Millar B, et al. Recruiting ent and audiology patients into pharmaceutical trials: evaluating the multi-centre experience in the uk and USA. Int J Audiol. 2018;57:S55–S66.
- Maas IL, Bruggemann P, Requena T, et al. Genetic susceptibility to bilateral tinnitus in a swedish twin cohort. Genet Med. 2017;19(9):1007–1012.
- Engineer ND, Riley JR, Seale JD, et al. Reversing pathological neural activity using targeted plasticity. Nature. 2011;470(7332):101–104.
- Tyler R, Cacace A, Stocking C, et al. Vagus nerve stimulation paired with tones for the treatment of tinnitus: A prospective randomized double-blind controlled pilot study in humans. Sci Rep. 2017;7(1):11960.
- De Ridder D, Vanneste S, Engineer ND, et al. Safety and efficacy of vagus nerve stimulation paired with tones for the treatment of tinnitus: A case series. Neuromodulation. 2014;17(2):170–179.
- Vanneste S, Martin J, Rennaker RLN, et al. Pairing sound with vagus nerve stimulation modulates cortical synchrony and phase coherence in tinnitus: an exploratory retrospective study. Sci Rep. 2017;7(1):17345.
- Londero A, Charpentier N, Ponsot D, et al. A case of acoustic shock with post-trauma trigeminal-autonomic activation. Front Neurol. 2017;8:420.
- Wu C, Martel DT, Shore SE. Increased synchrony and bursting of dorsal cochlear nucleus fusiform cells correlate with tinnitus. J Neurosci. 2016;36(6):2068–2073.
- Wu C, Martel DT, Shore SE. Transcutaneous induction of stimulus-timing-dependent plasticity in dorsal cochlear nucleus. Front Syst Neurosci. 2015;9:116.
- Koehler SD, Shore SE. Stimulus timing-dependent plasticity in dorsal cochlear nucleus is altered in tinnitus. J Neurosci. 2013;33(50):19647–19656.
- Marks KL, Martel DT, Wu C, et al. Auditory-somatosensory bimodal stimulation desynchronizes brain circuitry to reduce tinnitus in guinea pigs and humans. Sci Transl Med. 2018;10:422.
- Levine RA. Somatic (craniocervical) tinnitus and the dorsal cochlear nucleus hypothesis. Am J Otolaryngol. 1999;20(6):351–362.
- Sanchez TG, Rocha CB. Diagnosis and management of somatosensory tinnitus: review article. Clinics (Sao Paulo). 2011;66(6):1089–1094.
- Kleinjung T, Eichhammer P, Langguth B, et al. Long-term effects of repetitive transcranial magnetic stimulation (rtms) in patients with chronic tinnitus. Otolaryngol Head Neck Surg. 2005;132(4):566–569.
- Landgrebe M, Hajak G, Wolf S, et al. 1-hz rtms in the treatment of tinnitus: A sham-controlled, randomized multicenter trial. Brain Stimul. 2017;10:1112–1120.
- Tass PA, Adamchic I, Freund HJ, et al. Counteracting tinnitus by acoustic coordinated reset neuromodulation. Restor Neurol Neurosci. 2012;30:137–159.
- Haller M, Hall DA. Evaluation of the acoustic coordinated reset (cr(r)) neuromodulation therapy for tinnitus: update on findings and conclusions. Front Psychol. 2017;8:1893.
- Okamoto H, Stracke H, Stoll W, et al. Listening to tailor-made notched music reduces tinnitus loudness and tinnitus-related auditory cortex activity. Proc Natl Acad Sci USA. 2010;107(3):1207–1210.
- Stein A, Wunderlich R, Lau P, et al. Clinical trial on tonal tinnitus with tailor-made notched music training. BMC Neurol. 2016;16:38.
- Hamilton C, D’Arcy S, Pearlmutter BA, et al. An investigation of feasibility and safety of bi-modal stimulation for the treatment of tinnitus: an open-label pilot study. Neuromodulation. 2016;19(8):832–837.
- D’Arcy S, Hamilton C, Hughes S, et al. Bi-modal stimulation in the treatment of tinnitus: A study protocol for an exploratory trial to optimise stimulation parameters and patient subtyping. BMJ open. 2017;7(10):e018465.
- Turner JG, Brozoski TJ, Bauer CA, et al. Gap detection deficits in rats with tinnitus: A potential novel screening tool. Behav Neurosci. 2006;120(1):188–195.
- Turner JG, Parrish J. Gap detection methods for assessing salicylate-induced tinnitus and hyperacusis in rats. Am J Audiol. 2008;17(2):S185–192.
- Meikle MB, Henry JA, Griest SE, et al. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear Hear. 2012;33(2):153–176.
- Kalappa BI, Soh H, Duignan KM, et al. Potent kcnq2/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus. J Neurosci. 2015;35(23):8829–8842.
- Langguth B, Elgoyhen AB, Schlee W. Potassium channels as promising new targets for pharmacologic treatment of tinnitus: can internet-based ‘crowd sensing’ initiated by patients speed up the transition from bench to bedside?. Expert Opin Ther Targets. 2016;20(3):251–254.
- Elgoyhen AB, Langguth B, Nowak W, et al. Identifying tinnitus-related genes based on a side-effect network analysis. CPT Pharmacometrics Syst Pharmacol. 2014;3:e97.
- Probst T, Pryss RC, Langguth B, et al. Does tinnitus depend on time-of-day? An ecological momentary assessment study with the “trackyourtinnitus” application. Front Aging Neurosci. 2017;9:253.
- Basinou V, Park JS, Cederroth CR, et al. Circadian regulation of auditory function. Hear Res. 2016;347:47–55.
- Meltser I, Cederroth CR, Basinou V, et al. Trkb-mediated protection against circadian sensitivity to noise trauma in the murine cochlea. Curr Biol. 2014;24(6):658–663.
- Park JS, Cederroth CR, Basinou V, et al. Identification of a circadian clock in the inferior colliculus and its dysregulation by noise exposure. J Neurosci. 2016;36(20):5509–5519.
- Henry JA, Galvez G, Turbin MB, et al. Pilot study to evaluate ecological momentary assessment of tinnitus. Ear Hear. 2012;33(2):179–290.
- Cederroth CR, Basinou V, Park JS, et al. Circadian influences on the auditory system. In: Szczepek AJ, Mazurek B, editors. Tinnitus and stress. Springer International Publishing; 2017. p. 53–76.
- Ishida N, Matsui M, Mitsui Y, et al. Circadian expression of nmda receptor mrnas, epsilon 3 and zeta 1, in the suprachiasmatic nucleus of rat brain. Neurosci Lett. 1994;166(2):211–215.
- Yu H, Vikhe Patil K. C. H, Fabella B, Canlon B, Someya S, Cederroth CR: glast deficiency in mice exacerbates gap detection deficits in a model of salicylate-induced tinnitus. Front Behav Neurosci. 2016;10:158.
- Longenecker RJ, Galazyuk AV. Methodological optimization of tinnitus assessment using prepulse inhibition of the acoustic startle reflex. Brain Res. 2012;1485:54–62.
- Schilling A, Krauss P, Gerum R, et al. A new statistical approach for the evaluation of gap-prepulse inhibition of the acoustic startle reflex (gpias) for tinnitus assessment. Front Behav Neurosci. 2017;11:198.
- Schlee W, Hall D, Edvall NK, et al. Visualization of global disease burden for the optimization of patient management and treatment. Front Med (Lausanne). 2017;4. in press.
- Cook D, Brown D, Alexander R, et al. Lessons learned from the fate of astrazeneca’s drug pipeline: A five-dimensional framework. Nat Rev Drug Discov. 2014;13(6):419–431.
- Cederroth CR, Kähler A, Sullivan PF, et al. Genetics of tinnitus: time to biobank phantom sounds. Front Genet. 2017;8:110.
- Lopez-Escamez JA, Bibas T, Cima RF, et al. Genetics of tinnitus: an emerging area for molecular diagnosis and drug development. Front Neurosci. 2016;10:377.